Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OpenSight is a medical technology company, primarily known as a division of Novarad, that specializes in augmented reality (AR) solutions for surgical applications. The company developed the first FDA-cleared AR system for Microsoft HoloLens, designed specifically for preoperative surgical planning and visualization. By overlaying 3D patient imaging data directly onto the patient's body, OpenSight allows surgeons to visualize internal anatomy in relation to surface landmarks. This technology aims to improve surgical precision, reduce operative time, and enhance safety across various specialties, including orthopedics and interventional radiology. The platform integrates seamlessly with existing PACS systems to convert standard DICOM images into interactive 3D holograms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OpenSight.